OncoTroy is developing VSV-based novel oncolytic virus platform. The goal of their platform is to solve some of the current major hurdles on clinical translation of oncolytic viruses, such as antiviral immune response, safety concern and large capacity virus manufacturing. The platform can also be applied for generating viral vaccines.

OncoTroy